SILVERARC CAPITAL MANAGEMENT, LLC

CIK

1816307

Location

BOSTON, MA

Portfolio Value

Small $898,519,202

Diversification

Diversified

Reports for

SilverArc Capital, LLC

Filing Date

Global Rank

#2,073 / 8,700 ▲ 704

Top Industry

Biotechnology 89.3%

Period ended 2 months ago

Filed Aug 13, 2026 · 31d

23 quarters · since Dec 2020

Portfolio Concentration

65 tracked positions · as of Jun 30, 2026 · Δ vs Mar 31, 2026

Top Position

6.1%

−1.3 pts

Top 5

27.6%

−3.0 pts

Top 10

45.3%

−5.9 pts

HHI

305

Diversified−55

Portfolio Trend

23 quarters · across all stocks

Sector Breakdown

As of Jun 30, 2026

Sector	% Portfolio	Value	Positions
Healthcare	98.2%	$882,135,187	63
Financial Services	1.8%	$16,384,015	2

Last Quarter's Activity

Export CSV

Jun 30, 2026 vs Mar 31, 2026

Added To

Positions the filer increased

17 positions

Ticker	Company	Δ Shares	Shares	Value
IBIO	iBio, Inc.	+3,294,490	3,520,490	$6,160,857
OVID	Ovid Therapeutics Inc.	+2,101,129	3,101,129	$8,342,037
CCCC	C4 Therapeutics, Inc.	+1,120,275	3,032,060	$14,159,720
SNDX	Syndax Pharmaceuticals Inc	+325,403	1,214,390	$26,546,565
CERS	Cerus Corp	+296,190	3,472,737	$10,140,392
IMVT	Immunovant, Inc.	+204,860	619,096	$23,853,768
CMPS	COMPASS Pathways plc	+203,382	503,382	$7,122,855
ORKA	Oruka Therapeutics, Inc.	+201,894	352,802	$33,576,166
TRVI	Trevi Therapeutics, Inc.	+166,968	678,095	$12,646,471
IMNM	Immunome Inc.	+166,731	2,017,009	$42,740,420
CELC	Celcuity Inc.	+143,093	500,996	$52,414,201
VCYT	Veracyte, Inc.	+138,301	318,001	$18,676,198
ASND	Ascendis Pharma A/S	+81,576	206,234	$55,006,732
RYTM	Rhythm Pharmaceuticals, Inc.	+5,461	311,461	$34,581,514
SION	Sionna Therapeutics, Inc.	+3,061	42,478	$1,868,607
GH	Guardant Health, Inc.	+1,312	99,826	$14,976,894
PCVX	Vaxcyte, Inc.	+19	145,000	$8,428,850
No positions match the current search.

Trimmed

Positions the filer reduced

25 positions

Ticker	Company	Δ Shares	Shares	Value
GLUE	Monte Rosa Therapeutics, Inc.	−893,745	1,108,295	$26,820,739
ZBIO	Zenas BioPharma, Inc.	−626,146	509,789	$12,938,444
ERAS	Erasca, Inc.	−588,786	1,263,026	$23,138,636
KOD	Kodiak Sciences Inc.	−445,674	546,256	$21,282,133
ORIC	Oric Pharmaceuticals, Inc.	−361,137	738,873	$8,001,994
ALKS	Alkermes plc.	−346,820	113,494	$5,947,085
ELUT	Elutia Inc.	−305,040	2,192,980	$2,149,120
DNTH	Dianthus Therapeutics, Inc. /DE/	−264,746	390,000	$38,017,200
URGN	UroGen Pharma Ltd.	−201,066	1,301,979	$47,912,827
ABVX	Abivax S.A.	−132,937	169,593	$22,599,963
CGEN	Compugen Ltd	−131,588	3,184,257	$6,814,309
SYRE	Spyre Therapeutics, Inc.	−126,659	59,959	$5,323,160
TELA	TELA Bio, Inc.	−122,111	2,137,201	$1,602,900
IRON	Disc Medicine, Inc.	−113,228	82,800	$6,055,992
SVRA	Savara Inc	−75,523	1,355,459	$8,349,627
CBIO	Crescent Biopharma, Inc.	−71,396	59,104	$1,063,872
GUTS	Fractyl Health, Inc.	−63,649	1,637,976	$1,300,552
ABEO	Abeona Therapeutics Inc.	−38,535	610,407	$3,772,315
BNTC	Benitec Biopharma Inc.	−37,899	679,826	$9,096,071
COGT	Cogent Biosciences, Inc.	−33,482	1,280,707	$49,563,360
HLXC	Helix Acquisition Corp. III	−31,165	1,177,821	$12,532,015
ADGM	Adagio Medical Holdings, Inc.	−27,612	224,360	$146,282
XENE	Xenon Pharmaceuticals Inc.	−10,938	186,821	$11,276,515
PRAX	Praxis Precision Medicines, Inc.	−5,873	65,679	$21,988,672
CTNM	Contineum Therapeutics, Inc.	−5,594	296,135	$4,853,652
No positions match the current search.

New Positions

Positions the filer opened this quarter

20 positions

Ticker	Company	Shares	Value
ELVN	Enliven Therapeutics, Inc.	489,382	$24,836,136
SGMT	Sagimet Biosciences Inc.	2,927,698	$22,631,105
DFTX	Definium Therapeutics, Inc.	400,000	$18,816,000
ALXO	Alx Oncology Holdings Inc	5,744,757	$11,891,646
MANE	Veradermics, Inc	95,000	$11,679,300
AVLN	Avalyn Pharma Inc.	330,487	$10,879,632
ACRS	Aclaris Therapeutics, Inc.	1,946,482	$10,296,889
AVTX	Avalo Therapeutics, Inc.	500,402	$9,247,428
WGS	GeneDx Holdings Corp.	122,269	$8,393,766
SLDB	Solid Biosciences Inc.	668,450	$6,677,815
ARTV	Artiva Biotherapeutics, Inc.	525,000	$5,092,500
QURE	uniQure N.V.	105,000	$4,836,300
RACC	Research Alliance Corp III	360,000	$3,852,000
KPTI	Karyopharm Therapeutics Inc.	297,460	$2,906,184
RVMD	Revolution Medicines, Inc.	10,000	$1,872,800
ACHV	Achieve Life Sciences, Inc.	227,178	$1,483,472
CNTB	Connect Biopharma Holdings Ltd	545,000	$1,297,100
CLRB	Cellectar Biosciences, Inc.	321,728	$894,403
FHTX	Foghorn Therapeutics Inc.	45,975	$224,358
RCKT	Rocket Pharmaceuticals, Inc.	104,828	$0
No positions match the current search.

Sold Out

Positions the filer fully exited

21 positions

Ticker	Company	Shares	Value
SRRK	Scholar Rock Holding Corp	339,613	$16,695,375
CGON	CG Oncology, Inc.	166,349	$11,258,500
CLDX	Celldex Therapeutics, Inc.	178,378	$5,658,150
CYTK	Cytokinetics Inc	71,203	$4,692,989
CLYM	Climb Bio, Inc.	684,908	$4,691,619
CMPX	Compass Therapeutics, Inc.	859,049	$4,544,369
SRZN	Surrozen, Inc./DE	144,255	$4,202,148
ZURA	Zura Bio Ltd	560,651	$3,335,873
FULC	Fulcrum Therapeutics, Inc.	419,949	$3,221,008
ANNX	Annexon, Inc.	496,461	$2,750,393
MNPR	Monopar Therapeutics	43,488	$2,382,707
NXTC	NextCure, Inc.	176,057	$1,880,288
NMRA	Neumora Therapeutics, Inc.	818,156	$1,595,404
EWTX	Edgewise Therapeutics, Inc.	42,615	$1,342,372
REPL	Replimune Group, Inc.	171,936	$1,315,310
GENB	Generate Biomedicines, Inc.	100,000	$1,250,000
RADX	Radiopharm Theranostics Ltd	187,406	$805,845
AARD	Aardvark Therapeutics, Inc.	33,684	$126,988
—		2,876,407	$0
CNTA	Centessa Pharmaceuticals plc	466,345	$0
—		354,914	$0
No positions match the current search.

Portfolio Positions

Compact Export CSV View 13F filing

65 tracked positions · $898,519,202 total · filing declares 73 positions · $962,154,050 · as of Jun 30, 2026

All sectors Financial Services Healthcare

Showing 1–50 of 65 positions by value · page 1 of 2

Ticker	Company	Type	Shares	Δ Shares	Value (USD)	% Δ Value	% of Portfolio
ASND	Ascendis Pharma A/S Healthcare	Added	206,234	+81,576	$55,006,732	+92.9%	6.12%
CELC	Celcuity Inc. Healthcare	Added	500,996	+143,093	$52,414,201	+28.3%	5.83%
COGT	Cogent Biosciences, Inc. Healthcare	Reduced	1,280,707	-33,482	$49,563,360	−2.0%	5.52%
URGN	UroGen Pharma Ltd. Healthcare	Reduced	1,301,979	-201,066	$47,912,827	+77.3%	5.33%
IMNM	Immunome Inc. Healthcare	Added	2,017,009	+166,731	$42,740,420	+5.6%	4.76%
DNTH	Dianthus Therapeutics, Inc. /DE/ Healthcare	Reduced	390,000	-264,746	$38,017,200	−30.8%	4.23%
RYTM	Rhythm Pharmaceuticals, Inc. Healthcare	Added	311,461	+5,461	$34,581,514	+29.9%	3.85%
ORKA	Oruka Therapeutics, Inc. Healthcare	Added	352,802	+201,894	$33,576,166	+353.6%	3.74%
GLUE	Monte Rosa Therapeutics, Inc. Healthcare	Reduced	1,108,295	-893,745	$26,820,739	−18.6%	2.98%
SNDX	Syndax Pharmaceuticals Inc Healthcare	Added	1,214,390	+325,403	$26,546,565	+27.8%	2.95%
ELVN	Enliven Therapeutics, Inc. Healthcare	NEW	489,382	NEW	$24,836,136	NEW	2.76%
IMVT	Immunovant, Inc. Healthcare	Added	619,096	+204,860	$23,853,768	+131.8%	2.65%
ERAS	Erasca, Inc. Healthcare	Reduced	1,263,026	-588,786	$23,138,636	−22.8%	2.58%
SGMT	Sagimet Biosciences Inc. Healthcare	NEW	2,927,698	NEW	$22,631,105	NEW	2.52%
ABVX	Abivax S.A. Healthcare	Reduced	169,593	-132,937	$22,599,963	−32.9%	2.52%
PRAX	Praxis Precision Medicines, Inc. Healthcare	Reduced	65,679	-5,873	$21,988,672	−4.6%	2.45%
KOD	Kodiak Sciences Inc. Healthcare	Reduced	546,256	-445,674	$21,282,133	−43.7%	2.37%
DFTX	Definium Therapeutics, Inc. Healthcare	NEW	400,000	NEW	$18,816,000	NEW	2.09%
VCYT	Veracyte, Inc. Healthcare	Added	318,001	+138,301	$18,676,198	+222.7%	2.08%
GH	Guardant Health, Inc. Healthcare	Added	99,826	+1,312	$14,976,894	+64.6%	1.67%
CCCC	C4 Therapeutics, Inc. Healthcare	Added	3,032,060	+1,120,275	$14,159,720	+181.6%	1.58%
ZBIO	Zenas BioPharma, Inc. Healthcare	Reduced	509,789	-626,146	$12,938,444	−41.7%	1.44%
TRVI	Trevi Therapeutics, Inc. Healthcare	Added	678,095	+166,968	$12,646,471	+107.4%	1.41%
HLXC	Helix Acquisition Corp. III Financial Services	Reduced	1,177,821	-31,165	$12,532,015	+2.0%	1.39%
ALXO	Alx Oncology Holdings Inc Healthcare	NEW	5,744,757	NEW	$11,891,646	NEW	1.32%
MANE	Veradermics, Inc Healthcare	NEW	95,000	NEW	$11,679,300	NEW	1.30%
XENE	Xenon Pharmaceuticals Inc. Healthcare	Reduced	186,821	-10,938	$11,276,515	−1.9%	1.26%
AVLN	Avalyn Pharma Inc. Healthcare	NEW	330,487	NEW	$10,879,632	NEW	1.21%
BIIB	Biogen Inc. Healthcare	Reduced	48,101	-2,866	$10,392,702	+11.2%	1.16%
ACRS	Aclaris Therapeutics, Inc. Healthcare	NEW	1,946,482	NEW	$10,296,889	NEW	1.15%
CERS	Cerus Corp Healthcare	Added	3,472,737	+296,190	$10,140,392	+75.4%	1.13%
AVTX	Avalo Therapeutics, Inc. Healthcare	NEW	500,402	NEW	$9,247,428	NEW	1.03%
BNTC	Benitec Biopharma Inc. Healthcare	Reduced	679,826	-37,899	$9,096,071	+19.0%	1.01%
PCVX	Vaxcyte, Inc. Healthcare	Added	145,000	+19	$8,428,850	+0.0%	0.94%
WGS	GeneDx Holdings Corp. Healthcare	NEW	122,269	NEW	$8,393,766	NEW	0.93%
SVRA	Savara Inc Healthcare	Reduced	1,355,459	-75,523	$8,349,627	+6.9%	0.93%
OVID	Ovid Therapeutics Inc. Healthcare	Added	3,101,129	+2,101,129	$8,342,037	+275.8%	0.93%
ORIC	Oric Pharmaceuticals, Inc. Healthcare	Reduced	738,873	-361,137	$8,001,994	−42.6%	0.89%
CMPS	COMPASS Pathways plc Healthcare	Added	503,382	+203,382	$7,122,855	+329.3%	0.79%
CGEN	Compugen Ltd Healthcare	Reduced	3,184,257	-131,588	$6,814,309	−3.5%	0.76%
SLDB	Solid Biosciences Inc. Healthcare	NEW	668,450	NEW	$6,677,815	NEW	0.74%
IBIO	iBio, Inc. Healthcare	Added	3,520,490	+3,294,490	$6,160,857	+1334.8%	0.69%
IRON	Disc Medicine, Inc. Healthcare	Reduced	82,800	-113,228	$6,055,992	−51.7%	0.67%
ALKS	Alkermes plc. Healthcare	Reduced	113,494	-346,820	$5,947,085	−63.5%	0.66%
SYRE	Spyre Therapeutics, Inc. Healthcare	Reduced	59,959	-126,659	$5,323,160	−43.4%	0.59%
ARTV	Artiva Biotherapeutics, Inc. Healthcare	NEW	525,000	NEW	$5,092,500	NEW	0.57%
CTNM	Contineum Therapeutics, Inc. Healthcare	Reduced	296,135	-5,594	$4,853,652	+23.2%	0.54%
QURE	uniQure N.V. Healthcare	NEW	105,000	NEW	$4,836,300	NEW	0.54%
RACC	Research Alliance Corp III Financial Services	NEW	360,000	NEW	$3,852,000	NEW	0.43%
ABEO	Abeona Therapeutics Inc. Healthcare	Reduced	610,407	-38,535	$3,772,315	+29.8%	0.42%

Covers the securities this platform tracks: U.S.-listed common stock and the put/call positions reported on it. A 13F can also report security types outside that coverage — preferred shares, bonds, warrants, untracked share classes — so the filing's own declared total can exceed the figures above. The source filing is linked at the top of this table.